US Bancorp DE Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

US Bancorp DE trimmed its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 17.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,856 shares of the company’s stock after selling 386 shares during the quarter. US Bancorp DE’s holdings in VanEck Pharmaceutical ETF were worth $176,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Kingsview Wealth Management LLC boosted its stake in VanEck Pharmaceutical ETF by 1,104.4% in the first quarter. Kingsview Wealth Management LLC now owns 30,194 shares of the company’s stock valued at $2,739,000 after acquiring an additional 27,687 shares during the last quarter. Blair William & Co. IL increased its position in VanEck Pharmaceutical ETF by 92.7% in the first quarter. Blair William & Co. IL now owns 6,017 shares of the company’s stock worth $546,000 after buying an additional 2,894 shares during the last quarter. Spirepoint Private Client LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the first quarter valued at $995,000. Beck Capital Management LLC lifted its position in shares of VanEck Pharmaceutical ETF by 4.5% during the 1st quarter. Beck Capital Management LLC now owns 20,957 shares of the company’s stock valued at $1,901,000 after buying an additional 897 shares during the last quarter. Finally, Comerica Bank grew its stake in shares of VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after acquiring an additional 378 shares during the period.

VanEck Pharmaceutical ETF Stock Down 1.5 %

NASDAQ PPH opened at $88.17 on Friday. The company has a market cap of $651.58 million, a PE ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 52 week low of $76.31 and a 52 week high of $99.51. The firm’s 50-day simple moving average is $93.88 and its two-hundred day simple moving average is $92.99.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.